Hikma Pharmaceuticals PLC (HIK) — Capital Reinvestment Ratio
Hikma Pharmaceuticals PLC (HIK) has a Capital Reinvestment Ratio of 0.42x as of June 2025, meaning it reinvests 0% of its operating cash flow (GBX161.00 Million) in capital expenditures (GBX68.00 Million). See Hikma Pharmaceuticals PLC balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hikma Pharmaceuticals PLC Capital Reinvestment Ratio (2004–2024)
This chart tracks Hikma Pharmaceuticals PLC's Capital Reinvestment Ratio across 21 annual periods. Check HIK cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Hikma Pharmaceuticals PLC (2004–2024)
Year-by-year Capital Reinvestment Ratio for Hikma Pharmaceuticals PLC from 2004 to 2024. For live market cap and broader valuation context, see Hikma Pharmaceuticals PLC market capitalisation.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.29x | GBX564.00 Million | GBX165.00 Million | ▲ +5.2% |
| 2023 | 0.28x | GBX608.00 Million | GBX169.00 Million | ▼ -34.5% |
| 2022 | 0.42x | GBX530.00 Million | GBX225.00 Million | ▲ +18.3% |
| 2021 | 0.36x | GBX638.00 Million | GBX229.00 Million | ▼ -25.6% |
| 2020 | 0.48x | GBX464.00 Million | GBX224.00 Million | ▲ +22.5% |
| 2019 | 0.39x | GBX472.00 Million | GBX186.00 Million | ▲ +58.4% |
| 2018 | 0.25x | GBX430.00 Million | GBX107.00 Million | ▲ +3.0% |
| 2017 | 0.24x | GBX443.00 Million | GBX107.00 Million | ▼ -42.0% |
| 2016 | 0.42x | GBX293.00 Million | GBX122.00 Million | ▲ +85.8% |
| 2015 | 0.22x | GBX366.00 Million | GBX82.00 Million | ▲ +4.6% |
| 2014 | 0.21x | GBX425.00 Million | GBX91.00 Million | ▲ +22.3% |
| 2013 | 0.18x | GBX337.00 Million | GBX59.00 Million | ▼ -64.6% |
| 2012 | 0.50x | GBX182.16 Million | GBX90.19 Million | ▼ -34.8% |
| 2011 | 0.76x | GBX102.64 Million | GBX78.00 Million | ▲ +98.3% |
| 2010 | 0.38x | GBX138.79 Million | GBX53.20 Million | ▲ +0.2% |
| 2009 | 0.38x | GBX105.52 Million | GBX40.38 Million | ▼ -66.2% |
| 2008 | 1.13x | GBX57.87 Million | GBX65.52 Million | ▼ -11.2% |
| 2007 | 1.28x | GBX43.12 Million | GBX54.99 Million | ▼ -27.1% |
| 2006 | 1.75x | GBX29.99 Million | GBX52.44 Million | ▲ +138.5% |
| 2005 | 0.73x | GBX32.71 Million | GBX23.98 Million | ▲ +12.9% |
| 2004 | 0.65x | GBX32.84 Million | GBX21.33 Million | — |